Nature Communications, Published online: 15 June 2026; doi:10.1038/s41467-026-74363-8 This study reveals a novel, druggable route for SARS-CoV-2 infection and inflammatory responses in macrophages, thus expanding our understanding of COVID-19 pathogenesis and demonstrating a therapeutic target for infectious diseases.